Steven Pieper
Net worth: 6 M $ as of 31/05/2026
Net worth: 6 M $ as of 31/05/2026
Steven M.
Pieper is currently Chief Financial Officer at Xeris Biopharma Holdings, Inc. since 2021.
Formerly, Mr. Pieper was Finance Director at Durata Therapeutics, Inc., Chief Financial & Accounting Officer at Xeris Pharmaceuticals, Inc. in 2021, and Chief Operating & Financial Officer at Catheter Connections, Inc. from 2015 to 2017.
Education includes an undergraduate degree from DePaul University and an MBA from Loyola University of Chicago.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/04/2026 | 980,621 ( 0.57% ) | 6 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Director of Finance/CFO | 01/10/2021 |
| Companies | Position | End |
|---|---|---|
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Develops vascular access products | Director of Finance/CFO | 01/01/2017 |
| DURATA THERAPEUTICS INC | Director of Finance/CFO | 01/11/2014 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Director of Finance/CFO | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Develops vascular access products | Health Technology |
DePaul University
DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University of Chicago
Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Durata Therapeutics, Inc.
Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions